NCT00724880View on ClinicalTrials.gov

Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery.

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

December 31, 2007

Conditions
Coronary Artery Disease
Interventions
DRUG

Clopidogrel

Clopidogrel is stopped 5 days prior to surgery

DRUG

Clopidogrel

Clopidogrel is stopped 3 days prior to surgery

DRUG

Clopidogrel

Clopidogrel is stopped 0 days prior to surgery

All Listed Sponsors
lead

Catharina Ziekenhuis Eindhoven

OTHER

NCT00724880 - Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery. | Biotech Hunter | Biotech Hunter